The first batch of Russia's COVID-9 vaccine, Sputnik V has been produced for civilian circulation for those at a high risk of developing the novel coronavirus.

TOP INSIGHT
The first batch of Russia's COVID-19 vaccine, Sputnik V has been produced for civilian circulation. People at high-risk of developing COVID-19 will be vaccinated first. India and Russia are communicating regarding the vaccine.
Read More..
A study published in the journal The Lancet found that the Russian COVID-19 vaccine did not show any side effects, and it elicited an immune response in early human trials. The Lancet study's authors also held that large, long-term trials, including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing Covid-19 infection.
Russia is the first country to approve a COVID-19 vaccine, and on August 15, the Russian Health Ministry announced the launch of the vaccine production.
The Indian government said that New Delhi and Moscow are in communication regarding the Sputnik V vaccine.
Health Ministry Secretary Rajesh Bhushan said: "As far as Sputnik V vaccine is concerned, India and Russia are in communication, some initial information has been shared, and some detailed information is awaited".
Source-Medindia
MEDINDIA




Email










